Literature DB >> 23168771

Anthrax cases in pregnant and postpartum women: a systematic review.

Dana Meaney-Delman1, Marianne E Zotti, Sonja A Rasmussen, Sheryl Strasser, Sean Shadomy, Reina M Turcios-Ruiz, George D Wendel, Tracee A Treadwell, Denise J Jamieson.   

Abstract

OBJECTIVE: To describe the worldwide experience of Bacillus anthracis infection reported in pregnant, postpartum, and lactating women. DATA SOURCES: Studies were identified through MEDLINE, Web of Science, Embase, and Global Health databases from inception until May 2012. The key words (["anthrax" or "anthracis"] and ["pregna*" or "matern*" or "postpartum" or "puerperal" or "lact*" or "breastfed*" or "breastfeed*" or "fetal" or "fetus" or "neonate" or "newborn" or "abort*" or "uterus"]) were used. Additionally, all references from selected articles were reviewed, hand searches were conducted, and relevant authors were contacted. METHODS OF STUDY SELECTION: The inclusion criteria were: published articles referring to women diagnosed with an infection due to exposure to B anthracis during pregnancy, the postpartum period, or during lactation; any article type reporting patient-specific data; articles in any language; and nonduplicate cases. Non-English articles were professionally translated. Duplicate reports, unpublished reports, and review articles depicting previously identified cases were excluded. TABULATION, INTEGRATION, AND
RESULTS: Two authors independently reviewed articles for inclusion. The primary search of the four databases yielded 1,340 articles, and the secondary crossreference search revealed 146 articles. Fourteen articles met the inclusion criteria. In total, 20 cases of B anthracis infection were found, 17 in pregnant women, two in postpartum women, and one case in a lactating woman. Among these reports, 16 women died and 12 fetal or neonatal losses were reported. Of these fatal cases, most predated the advent of antibiotics.
CONCLUSIONS: Based on these case reports, B anthracis infection in pregnant and postpartum women is associated with high rates of maternal and fetal death. Evidence of possible maternal-fetal transmission of B anthracis infection was identified in early case reports.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23168771     DOI: 10.1097/aog.0b013e318270ec08

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  6 in total

Review 1.  Antitoxin Treatment of Inhalation Anthrax: A Systematic Review.

Authors:  Eileen Huang; Satish K Pillai; William A Bower; Katherine A Hendricks; Julie T Guarnizo; Jamechia D Hoyle; Susan E Gorman; Anne E Boyer; Conrad P Quinn; Dana Meaney-Delman
Journal:  Health Secur       Date:  2015 Nov-Dec

2.  Cutaneous Anthrax on Eyelid in a Pregnant Woman.

Authors:  Emine Parlak; Ayse Erturk; Serpil Erol; Mehmet Parlak; Zulal Ozkurt
Journal:  Eurasian J Med       Date:  2016-06

3.  Plague and Pregnancy: Why Special Considerations Are Needed.

Authors:  Dana Meaney-Delman; Nadia L Oussayef; Margaret A Honein; Christina A Nelson
Journal:  Clin Infect Dis       Date:  2020-05-21       Impact factor: 9.079

4.  Special considerations for prophylaxis for and treatment of anthrax in pregnant and postpartum women.

Authors:  Dana Meaney-Delman; Marianne E Zotti; Andreea A Creanga; Lara K Misegades; Etobssie Wako; Tracee A Treadwell; Nancy E Messonnier; Denise J Jamieson
Journal:  Emerg Infect Dis       Date:  2014-02       Impact factor: 6.883

5.  Severe Coronavirus Infections in Pregnancy: A Systematic Review.

Authors:  Romeo R Galang; Karen Chang; Penelope Strid; Margaret Christine Snead; Kate R Woodworth; Lawrence D House; Mirna Perez; Wanda D Barfield; Dana Meaney-Delman; Denise J Jamieson; Carrie K Shapiro-Mendoza; Sascha R Ellington
Journal:  Obstet Gynecol       Date:  2020-08       Impact factor: 7.623

6.  Protective Immune Response against Bacillus anthracis Induced by Intranasal Introduction of a Recombinant Adenovirus Expressing the Protective Antigen Fused to the Fc-fragment of IgG2a.

Authors:  D N Shcherbinin; I B Esmagambetov; A N Noskov; Yu O Selyaninov; I L Tutykhina; M M Shmarov; D Yu Logunov; B S Naroditskiy; A L Gintsburg
Journal:  Acta Naturae       Date:  2014-01       Impact factor: 1.845

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.